Dealmaking

Inflexion’s Axiom GRC makes second US acquisition; Main, GCP and LDC looking at international expansion for new investments

Main, GCP and LDC on the hunt for international expansion for new investments.

Growth of GP-led single-asset CVs is ‘long-term and secular,’ says Pantheon’s Amyn Hassanally; Deal of the Year submissions are due Jan 23

A Q&A with Amyn Hassanally, a partner and global head of private equity secondaries at Pantheon, to find out if GP-led CVs will continue in 2026; a preview of PEI Group’s NEXUS 2026 conference next month in Orlando; a reminder that Friday, January 23 is the deadline for submitting transactions completed in 2025 for PE Hub’s Deal of the Year Awards.

GP-led single-asset CVs used for 'high-quality trophy assets,' says Pantheon's Amyn Hassanally

The continuation vehicle is being 'embraced widely by the GP community as a viable alternative to traditional exit options, with lots of room to run.'

Tikehau Capital’s Emmanuel Laillier: Newcomers to defense deals still in ‘training curve’; Bridgepoint, Carlyle, HIG, LLCP and Oakley in dealmaking action

Glas is a global provider of loan administration and bond trustee services.

Tikehau’s Emmanuel Laillier: No sign yet of extra GP competition for European defense assets

The GP’s background in aerospace and defense is attracting more European LPs.

A new hope: What GPs expect from private equity in 2026

Private equity managers are once again hoping to break the dealmaking dam in the year ahead.

CapMan, Clearstone and other GPs target nutrition; Fifth Third, Truist Securities make precision healthcare and IPO predictions

The tailwinds behind recent deals in the nutrition brands space; predictions from investment banks on what to expect in precision healthcare and the IPO market for 2026.

PE fuels up on better-for-you nutrition: 6 deals

Butterfly Equity, CapMan, Clearstone and Fondaction are among the PE firms transacting in the better-for-you nutrition sector.

Meet venture capital’s 2026 Rising Stars

We are proud to present Venture Capital Journal’s seventh annual list of 40 Rising Stars under the age of 40.

PAI: Narrowing valuation gaps fueling competition for top assets; Key themes for PE dealmaking in 2026

PAI is entering 2026 with a strong pipeline shaped by Europe’s favorable macroeconomic backdrop, says co-managing partner Frédéric Stévenin.